GERN Geron Corporation: Stock Price

The current Geron Corporation (GERN) share price chart on the GURU.Markets platform, where the indicator stands at 0.97, demonstrates the success of a pioneer in developing telomerase inhibitors. A lack of competitors and robust patent protection allow the brand to pursue market dominance. The approval of Rytelo has elevated the company's image to a new level, strengthening investor confidence in its scientific potential. Global recognition in the therapy of blood diseases confirms its status as an expert saving thousands of lives.

Price Performance Chart: Geron Corporation (GERN) for 07/04/2022 - 11/15/2026

Summary analytical data breakdowns for Geron Bio (GERN)

- stock quotes and analyst forecast:

Stock Price geron.com|GERN - Analyst Target Range

- company stock capitalization data:

Market Capitalization Geron Corp|GERN - Total Enterprise Value

- book capitalization information:

Net Assets per Single Share Geron|GERN - Accounting Value of Company|Market Value to Book Value Ratio geron.com|GERN - Total Business Assets

- debt level and financial liquidity data:

- company profitability and valuation multiples indicators:

GERN - Company Net Income|Expected Profit Geron Corporation|GERN - Market Cap to Earnings|Forward P/E Multiple Geron Corp|GERN - Price to Net Income Growth Ratio|Enterprise Value to EBITDA Ratio Geron Corp|GERN - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Geron|GERN - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months geron.com|GERN - Earnings per share trend in current year|Net earnings per share growth forecast for next year Geron Corporation

- sales volume and revenue information:

GERN - Company Revenue|Projected Sales Volume geron.com|GERN - P/S Multiple|Forward Price-to-Revenue Multiple Geron Corp|GERN - Revenue Change YoY (Last 12 Months)

Summary company analytics:Geron Corp

Active hiring of commercial specialists at Geron Corporation signals the company's transition to the monetization stage of its developments. The stock price trajectory reflects the real-time market valuation of this strategic shift. The price captures current demand for a single share of the business, determining the entry point for investors. Price action measures aggregate market expectations regarding future cash flows. The stability of the chart confirms the asset's investment attractiveness.

Competitors of Geron Corporation